RGT 6.25% 30.0¢ argent biopharma limited

Ann: December Quarterly Activity and Cashflow Report, page-3

  1. 1,308 Posts.
    lightbulb Created with Sketch. 583
    Wow, what a great result lol

    Basically no increase in revenue. Less than should have been expected based on announcements and previous reports. How much of the revenue was for Pharma products? Over promising and under delivering continues by the look of it. Still haven't even received the money reported in the 'receivables" within the annual report.

    Cost of sales still outweighing sales revenue.

    Spent approx $900k more than expected outflows as per last reported qtrly. Broke, with less than a qtr cash in bank.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.020(6.25%)
Mkt cap ! $15.48M
Open High Low Value Volume
30.0¢ 30.0¢ 30.0¢ $2.481K 8.27K

Buyers (Bids)

No. Vol. Price($)
2 8270 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 5000 1
View Market Depth
Last trade - 10.19am 05/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.